CATEGORY
HAS
- ABPI
- ACE
- ACIS
- Adelaide
- Aetsa
- Agenas
- AHRQ
- AIFA
- AMNOG
- ANVISA
- AOTMiT
- AQuAS
- Behandlingsraadet
- BfArM
- Biocat
- C2H
- CADTH
- CDC
- CDE
- CMS
- COFEPRIS
- CONITEC
- Digemid
- EFPIA
- EMA
- EPF
- Eucope
- EUnetHTA
- EuropaBio
- European Commission
- Euskadi
- FDA
- FOPH
- G-BA
- Gesundheit Österreich
- HAS
- Health Technology Wales
- Healthcare Improvement Scotland
- HHS
- HIQA
- HTAi
- ICER
- IECS
- IETS
- IHE
- IHEA
- INAHTA
- IQWiG
- ISPOR
- KCE
- Medicaid
- Medicines for Europe
- MHRA
- MSP
- NECA
- NHS
- nHTA
- NICE
- NIH
- NIHO
- NIHR
- NIPH
- NSW Health
- NZa
- OHE
- OYS
- PBS
- pCPA
- Pharmac
- PhRMA
- Salute
- SBU
- Schönermark Kielhorn Collegen
- SGK
- TÄ°TCK
- TLV
- WHO
- ZonMw
- Zorginstituut Nederland
Everyday Accidents Lead to 550,000 Medical Consultations in Children Under 15 Annually
GYNECARE GYNEMESH PS Withdrawn from French Market for Pelvic Organ Prolapse Treatment
French Health Authority Updates on Medical Device Reimbursement
HAS Evaluates Gene Panels for Oncology in France
France’s July 2024 Add-On Medical Devices Reimbursement Recommendations
Key Recommendations on Medical Devices Reimbursement and Accessibility in France by HAS
November 2023 Guidelines: Reimbursement Insights for Medical Device Add-ons in France
France’s Early Access to Medicines Program: A Successful Two-Year Journey
French National Authority for Health Issues New Guidelines on Medical Device Reimbursement
French National Authority for Health Issues Recommendations on Medical Device Reimbursement